BD to Announce Financial Results for its Third Quarter of Fiscal 2025

Rhea-AI Summary

BD (NYSE: BDX) has announced it will host an audio webcast on August 7, 2025, at 8 a.m. ET to discuss its third quarter fiscal 2025 financial results. The quarter ends on June 30, 2025. During the webcast, management will present the quarterly financial performance and provide updates on the company's operations and strategy.

The webcast will be accessible through BD's investor relations website, with presentation materials and a summary of financial information to be released prior to the call. A replay of the webcast will be available on the same website shortly after the event.

News Market Reaction – BDX

+4.86%

1 alert

+4.86% News Effect

On the day this news was published, BDX gained 4.86%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FRANKLIN LAKES, N.J., May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 7, 2025 to discuss the Company's financial results for its third quarter of fiscal year 2025, which ends on June 30, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made available shortly after the call at the same website. Prior to the call, the Company will issue a news release and related presentation materials that will include summary financial information for the quarter.  The news release and related presentation materials will be made available at www.bd.com/investors.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:

Media: Troy Kirkpatrick VP, Public Relations 858.617.2361 troy.kirkpatrick@bd.com

Investors: Adam Reiffe Sr. Director, Investor Relations 201.847.6927   adam.reiffe@bd.com

View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2025-302451835.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD (BDX) report its Q3 2025 earnings?

BD will report its Q3 2025 earnings on Thursday, August 7, 2025, at 8 a.m. ET via an audio webcast.

Where can I access BD's (BDX) Q3 2025 earnings webcast?

The earnings webcast can be accessed through BD's investor relations website at www.bd.com/investors. A replay will be available on the same website after the call.

What period does BD's (BDX) Q3 2025 fiscal quarter cover?

BD's third quarter of fiscal year 2025 covers the period ending June 30, 2025.

What materials will BD (BDX) provide before the Q3 2025 earnings call?

Prior to the call, BD will release a news release and presentation materials including summary financial information for the quarter on www.bd.com/investors.